Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Menne, Jan

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. [electronic resource] - BMC nephrology 04 2019 - 125 p. digital

Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

1471-2369

10.1186/s12882-019-1314-1 doi


Adolescent
Adult
Antibodies, Monoclonal, Humanized--administration & dosage
Atypical Hemolytic Uremic Syndrome--complications
Child
Complement Inactivating Agents--administration & dosage
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
International Cooperation
Long Term Adverse Effects--diagnosis
Male
Medication Therapy Management
Outcome and Process Assessment, Health Care
Thrombotic Microangiopathies--diagnosis